© Grace Therapeutics, Inc. All Rights Reserved.

Grace’s illustrious Board of Directors provide strategic guidance as we develop and commercialize innovative products and build a world class pharmaceutical company.

Board of Directors

Vimal Kavuru

Co-founder & Chairman of Grace Therapeutics

S George Kottayil, Ph.D.

Co-founder & CEO of Grace Therapeutics

William A. Haseltine, Ph.D.

Former CEO of Human Genome Sciences, Inc.

Chairman and President of ACCESS Health International, Inc.

Chairman of the Haseltine Foundation for Science and the Arts

Grace Scientific Advisory Board (SAB) provides strategic guidance and direction for our research and scientific programs.

GTX-101 Scientific Advisory Board

Robert Dworkin, Ph.D.

Professor of Anesthesiology, Neurology, Oncology and Psychiatry at University of Rochester School of Medicine and Dentistry

Director, Anesthesiology Clinical Research Center

Roy Freeman, M.D.

Professor of Neurology at Harvard Medical School

Director, Center for Autonomic and Peripheral Nerve Disorders at Beth Israel Deaconess Medical Center

Nathaniel Katz, M.D., M.S.

CEO, Analgesic Solutions

Richard Rauck, M.D.

Clinical Associate Professor of the Department of Anesthesiology at Wake Forest University School of Medicine

President, World Institute of Pain

Neil Singla, M.D.

Chief Scientific Officer, Lotus Clinical Research

Michael Rowbotham, MD

Professor of Anesthesia, at UCSF School of Medicine

Senior Scientist and Scientific Director of the California Pacific Medical Center Research Institute

GTX-102 Scientific Advisory Board

Richard Gatti, M.D, Ph.D.

Professor of Pathology and Laboratory Medicine and Professor in Residence of Human Genetics at UCLA Geffen School of Medicine

Scientific Director, Ataxia-Telangiectasia Medical Research Foundation (1984-present)

Scientific Director, Neuromuscular Diseases Foundation (2006-present)

Howard M. Lederman, M.D., Ph.D.

Professor Pediatrics at The Johns Hopkins University School of Medicine

Director, Immunodeficiency Clinic, Pediatric Immunology Laboratory, and Ataxia-Telangiectasia (A-T) Clinical Center, Johns Hopkins University

Thomas Crawford, M.D.

Professor of Neurology and Pediatrics at The Johns Hopkins University School of Medicine

Neurologist, Ataxia-Telangiectasia (A-T) Clinical Center, Johns Hopkins University

GTX-104 Scientific Advisory Board

James Longstrethh Ph.D.

PK Consultant and Founder Longstreth & Associates Inc